Vaccines highly effective against B.1.617.2 variant after 2 doses
New study by PHE shows for the first time that 2 doses of the COVID-19 vaccines are highly effective against the B.1.617.2 variant first identified in India.
New study by PHE shows for the first time that 2 doses of the COVID-19 vaccines are highly effective against the B.1.617.2 variant first identified in India.
Technical briefing documents on novel SARS-CoV-2 variants.
Risk assessments for SARS-CoV-2 variants.
Data on the real-world efficacy of the COVID-19 vaccines.
Data reports on novel SARS-CoV-2 variants.